Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock opened at $0.00 on Wednesday. The company has a market cap of $2,951.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. The business’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.03. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $2.91.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.